Filing Flows › Bio-Rad Laboratories (BIO) › Q2 2026
Bio-Rad Laboratories (BIO) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 4, 2026
Bio-Rad Laboratories (BIO) reported revenue of $651M for the second quarter 2026 (Q2 2026), -0.1% from a year earlier and +10% from the quarter before. Operating margin was 11.2%, net earnings $371M (57.1% of revenue).
Bio-Rad Laboratories, Q2 2026: revenue $651M (-0.1% year over year), operating margin 11.2%, net earnings $371M, operating cash flow $98.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $651M | +10% | -0.1% |
| Gross profit | $346M | +12% | +0.1% |
| Operating profit | $72.6M | +113% | -6% |
| Net earnings | $371M | — | +17% |
| Operating cash flow | $98.7M | -9% | -15% |
| Free cash flow | $66.7M | -15% | -6% |
What changed
Revenue was $651.0M in Q2 2026, roughly flat year over year and up 10% from the previous quarter. Clinical Diagnostics was the largest line at 61% of revenue. Life Science lost $10.8M year over year (down 4%), 1800% of the total change.
Gross margin was 53.1%, up 0.1 points from Q2 2025. Operating profit was $72.6M, a 11.2% margin (down 0.7 points year over year). Operating expenses grew 2% against flat revenue. Net earnings were $371.4M, up 17% year over year. The effective tax rate was 31.5%. Non-operating items added $469.5M, 87% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $98.7M (down 15% year over year), 27% of net earnings. Non-cash charges added back $14.5M of share-based compensation. Working capital and other items used $287.2M. Capital expenditures of $32.0M left free cash flow of $66.7M.
Questions
What was Bio-Rad Laboratories' revenue in the second quarter 2026?
Bio-Rad Laboratories (BIO) reported revenue of $651M for the second quarter 2026 (Q2 2026), -0.1% from a year earlier and +10% from the quarter before.
Was Bio-Rad Laboratories profitable in the second quarter 2026?
Operating profit was $72.6M (11.2% of revenue) and net earnings $371M.